Headquartered in Geneva, Switzerland, TRB Chemedica describes itself online as “a medium-sized pharmaceutical company, with a focus on research, development, and marketing of innovative niche products in specific therapeutic areas, including rheumatology, ophthalmology, and neurology. We market a range of ethical pharmaceuticals and medical devices, most of which are patented, in more than 40 countries worldwide.”
Recently, TRB Chemedica became the first to use of Aptar Pharma’s patented preservative-free multidose Opthalmic Squeeze Dispenser (OSD) for VISMED® MULTI for the treatment of dry eye.
The device consists of six components including a protection cap, with a separate 10-mL low-density polyethylene container manufactured by a supplier in Germany. All of the OSD's plastic components are molded and assembled under ISO 7 cleanroom conditions at Aptar Pharma’s plant in Eigeltingen, Germany. Aptar says the OSD components are made of standard pharmaceutical-grade polyethylenes, polypropylenes, and thermoplastic elastomers. A high-grade stainless-steel spring, procured from a local manufacturer, is used to ensure the tip-seal function without contacting the formulation. A filter membrane is made of a double layer of DuPont Teflon® material.
